RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?Tencents wrote: Seems not a bad offer to have a small royalty in a 40 billion market - trying to be too big is risky
bellus sold out to Gsk recently and picked up 2 billion rather than trying to go alone
Bellus was in Phase III human testing. Should Bellus have given up control preclinically with mouse data alone? It would have been a Mickey Mouse deal. It would not have been a $2 billion takeover. CZO used the protoytpe PGX- oat beta glucan to inform the development path of more promising carriers. With promising carriers in hand, as informed by talks with industry, Gilles is scaling up to the point of 100L which will take PGX to commercial-scale for the first time. Just as Bellus advanced its technology to late-stage development CZO is advancing PGX to late-stage development.
Once you give up control you have also given up control. There is no guarenteee it advances much at all. Big companies have many priorities. They can also sue you and try to find work-arounds. 90% of Novo Nordisk's growth hormone deficiency drug sales are to children and there is a question how much it prioritized investing in the adult market. Novo ended up terminating the relationship with AEZS. Gilles was the one to turn PGX oat beta glucan into PGX-YBG. The potential is much bigger given where CZO stands now with its second generation carriers. PGX- oat beta glucan was a prototype and deemed non-feasible due to costs. It was only pilot-lab scale. It wasn't advanced like Bellus' drug.